CONMED Corporation (CNMD)

NYSE Health Care Health Care Equipment S&P SmallCap 600
$51.50
-1.33 (-2.52%)
Close of Nov 06, 2026 · end-of-day data
Source: CONMED Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$763.52M$796.39M$859.63M$955.10M$862.46M$1.01B$1.05B$1.24B$1.31B$1.37B
Cost of revenue$355.19M$365.35M$390.52M$430.38M$402.16M$442.60M$474.23M$568.50M$573.98M$624.25M
Gross profit$408.33M$431.04M$469.11M$524.72M$460.30M$568.04M$571.25M$676.25M$733.03M$750.48M
Research & development$32.25M$32.31M$42.19M$45.46M$40.47M$43.56M$47.15M$52.60M$54.43M$55.88M
Selling, general & admin$338.40M$351.80M$355.62M$400.14M$373.82M$414.75M$454.04M$503.04M$478.28M$591.97M
Operating income$37.68M$46.94M$71.31M$79.11M$46.01M$109.72M$70.05M$120.60M$200.33M$102.62M
Interest expense$15.36M$18.20M$20.65M$42.70M$44.05M$35.48M$28.91M$39.77M$37.30M$31.09M
Pre-tax income$19.38M$28.73M$50.65M$31.23M$1.60M$73.11M-$70.86M$80.83M$163.03M$71.12M
Income tax$4.71M-$26.75M$9.80M$2.60M-$7.91M$10.56M$9.72M$16.37M$30.61M$24.06M
Net income$14.66M$55.49M$40.85M$28.62M$9.52M$62.54M-$80.58M$64.46M$132.42M$47.05M
EBITDA$58.16M$67.01M$89.83M$97.80M$64.05M$126.21M$86.11M$136.80M$216.93M$119.77M
EPS (basic)$0.53$1.99$1.45$1.01$0.33$2.14$-2.68$2.10$4.29$1.52
EPS (diluted)$0.52$1.97$1.41$0.97$0.32$1.94$-2.68$2.04$4.25$1.51
Diluted shares27.96M28.17M28.89M29.50M29.46M32.22M30.04M31.55M31.15M31.15M
Gross margin53.5%54.1%54.6%54.9%53.4%56.2%54.6%54.3%56.1%54.6%
Operating margin4.9%5.9%8.3%8.3%5.3%10.9%6.7%9.7%15.3%7.5%
Net margin1.9%7.0%4.8%3.0%1.1%6.2%-7.7%5.2%10.1%3.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$27.43M$32.62M$17.51M$25.86M$27.36M$20.85M$28.94M$24.30M$24.46M$40.82M
Receivables$148.24M$167.04M$181.55M$189.10M$177.15M$183.88M$191.34M$242.28M$237.73M$247.83M
Inventory$135.87M$141.44M$154.60M$164.62M$194.87M$231.64M$332.32M$318.32M$346.72M$355.54M
Total current assets$330.51M$356.78M$374.35M$397.36M$416.65M$460.12M$581.23M$615.65M$640.01M$672.86M
Goodwill$397.66M$401.95M$400.44M$618.04M$618.44M$617.53M$815.43M$806.84M$805.36M$807.01M
Total assets$1.33B$1.36B$1.37B$1.78B$1.75B$1.77B$2.30B$2.30B$2.31B$2.33B
Total current liabilities$113.95M$150.00M$160.94M$188.09M$190.20M$196.65M$296.55M$310.73M$278.13M$315.04M
Short-term debt$10.20M$14.70M$18.34M$13.60M$18.41M$12.25M$69.75M$708.00K$715.00K$712.00K
Long-term debt$488.29M$471.74M$438.56M$755.21M$735.22M$672.41M$985.08M$973.14M$905.07M$834.23M
Total debt$498.49M$486.44M$456.90M$768.81M$753.64M$684.66M$1.05B$973.85M$905.78M$834.94M
Total liabilities$748.41M$726.53M$706.87M$1.06B$1.04B$980.58M$1.55B$1.47B$1.34B$1.29B
Shareholders' equity$580.58M$631.43M$662.27M$710.47M$709.04M$785.43M$745.54M$834.22M$962.68M$1.03B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$39.88M$65.57M$74.70M$95.13M$64.53M$111.77M$33.37M$125.35M$166.97M$170.69M
Capital expenditures$14.75M$12.84M$16.51M$20.07M$13.01M$14.87M$21.79M$19.03M$13.08M$19.81M
Free cash flow$25.13M$52.72M$58.19M$75.07M$51.52M$96.90M$11.58M$106.32M$153.88M$150.88M
Investing cash flow-$266.02M-$29.05M-$16.51M-$387.66M-$13.64M-$14.87M-$249.53M-$20.03M-$13.08M-$20.96M
Financing cash flow$182.54M-$34.88M-$72.27M$300.88M-$52.06M-$101.55M$225.00M-$110.43M-$151.00M-$135.82M
Dividends paid$22.21M$22.31M$22.44M$22.60M$22.82M$23.26M$23.96M$24.50M$24.65M$24.75M
Share buybacks$0—————————
Stock-based compensation$8.38M$8.47M$10.04M$11.78M$13.11M$16.34M$21.73M$24.26M$25.56M$28.32M
Depreciation & amortization$20.48M$20.08M$18.53M$18.69M$18.04M$16.49M$16.05M$16.20M$16.61M$17.14M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.